Page last updated: 2024-08-23

androstane-3,17-diol and Hypercholesterolemia

androstane-3,17-diol has been researched along with Hypercholesterolemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adlercreutz, H; Hautanen, A; Manninen, V; Mänttäri, M	1

Other Studies

1 other study(ies) available for androstane-3,17-diol and Hypercholesterolemia

Article	Year
Gemfibrozil treatment is associated with elevated adrenal androgen, androstanediol glucuronide and cortisol levels in dyslipidemic men. The Journal of steroid biochemistry and molecular biology, 1994, Volume: 51, Issue:5-6 Topics: Adrenal Cortex Hormones; Adult; Androgens; Androstane-3,17-diol; Case-Control Studies; Cholesterol, HDL; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Gemfibrozil; Humans; Hydrocortisone; Hypercholesterolemia; Linear Models; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone	1994

Article

Year

Gemfibrozil treatment is associated with elevated adrenal androgen, androstanediol glucuronide and cortisol levels in dyslipidemic men.

The Journal of steroid biochemistry and molecular biology, 1994, Volume: 51, Issue:5-6

Topics: Adrenal Cortex Hormones; Adult; Androgens; Androstane-3,17-diol; Case-Control Studies; Cholesterol, HDL; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Gemfibrozil; Humans; Hydrocortisone; Hypercholesterolemia; Linear Models; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone

1994